Cannabinoid R1/CB1/CNR1 Antibody (nimacimab) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28124F
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Recombinant Monoclonal Human IgG4 Clone # nimacimab
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CB1 / CNR1
Clonality
Monoclonal
Host
Human
Isotype
IgG4
Applications for Cannabinoid R1/CB1/CNR1 Antibody (nimacimab) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cannabinoid R1/CB1/CNR1
Long Name
Cannabinoid Receptor 1
Alternate Names
CANN6, CannabinoidR1, CB-R, CB1, CB1A, CB1K5, CB1R, CNR1, SKR6R
Gene Symbol
CNR1
Additional Cannabinoid R1/CB1/CNR1 Products
Product Documents for Cannabinoid R1/CB1/CNR1 Antibody (nimacimab) [FITC]
Product Specific Notices for Cannabinoid R1/CB1/CNR1 Antibody (nimacimab) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...